EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16

Weerayut Wongjampa iD, Tomomi Nakahara, Katsuyuki Tanaka, Takashi Yugawa, Tipaya Ekalaksananan, Pilaiwan Kleebkaow, Naoki Goshima, Tohru Kiyono iD, Chamsai Pientong iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Weerayut Wongjampa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Microbiology, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Oncogene Proteins, Viral, Papillomavirus Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research, Khon Kaen University, The Program Management Unit for Human Resources & Institutional Development, Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deregulated expression of viral E6 and E7 genes often caused by viral genome integration of high-risk human papillomaviruses (HR-HPVs) into host DNA and additional host genetic alterations are thought to be required for the development of cervical cancer. However, approximately 15% of invasive cervical cancer specimens contain only episomal HPV genomes. In this study, we investigated the tumorigenic potential of human cervical keratinocytes harboring only the episomal form of HPV16 (HCK1T/16epi). We found that the HPV16 episomal form is sufficient for promoting cell proliferation and colony formation of parental HCK1T cells. Ectopic expression of host oncogenes, MYC and PIK3CA E545K , enhanced clonogenic growth of both early- and late-passage HCK1T/16epi cells, but conferred tumor-initiating ability only to late-passage HCK1T/16epi cells. Interestingly, the expression levels of E6 and E7 were rather lower in late-passage than in early-passage cells. Moreover, additional introduction of a constitutively active MEK1 ( MEK1DD) and/or KRAS G12V into HCK1T/16epi cells resulted in generation of highly potent tumor-initiating cells. Thus an in vitro model for progression of cervical neoplasia with episomal HPV16 was established. In the model, constitutively active mutation of PIK3CA, PIK3CA E545K , and overexpression of MYC , in the cells with episomal HPV16 genome were not sufficient, but an additional event such as activation of the RAS-MEK pathway was required for progression to tumorigenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsOncogene Proteins, ViralPapillomavirus InfectionsFemaleHumansHuman papillomavirus 16Cervix UteriCarcinogenesisPapillomavirus E7 Proteins

Substanzen

Oncogene Proteins, ViralPapillomavirus E7 Proteins

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Microbiology, Khon Kaen University, Khon Kaen, Thailand.
  • HPV & EBV and Carcinogenesis Research Group, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan.
  • Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo, Japan.
  • Department of Basic Medical Research, Division of Basic Medical Research, Japan Agency for Medical Research and Development, Tokyo, Japan.
  • Faculty of Medicine, Department of Obstetrics and Gynecology, Khon Kaen University, Khon Kaen, Thailand.

ORCID-Profile: Weerayut Wongjampa, Tohru Kiyono, Chamsai Pientong

Förderung

  • Japan Agency for Medical Research
  • Khon Kaen University
  • The Program Management Unit for Human Resources & Institutional Development, Research and Innovation
  • The Post-Doctoral Training Program from Khon Kaen University, Thailand
  • Research and Graduate Studies, Khon Kaen University

Zitieren

APA

Wongjampa, W., Nakahara, T., Tanaka, K., Yugawa, T., Ekalaksananan, T., Kleebkaow, P., Goshima, N., Kiyono, T., & Pientong, C. (2023). An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16. PLOS ONE. https://doi.org/10.1371/journal.pone.0281069

Vancouver

Wongjampa W, Nakahara T, Tanaka K, Yugawa T, Ekalaksananan T, Kleebkaow P, et al. An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16. PLOS ONE. 2023. doi:10.1371/journal.pone.0281069

BibTeX
@article{Wongjampa2023,
  author = {Wongjampa, Weerayut and Nakahara, Tomomi and Tanaka, Katsuyuki and Yugawa, Takashi and Ekalaksananan, Tipaya and Kleebkaow, Pilaiwan and Goshima, Naoki and Kiyono, Tohru and Pientong, Chamsai},
  title = {An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281069}
}
Kostenlos starten →